Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs SC Insulin in Hospitalised Type 2 Diabetes
NCT00135070Phase 4Terminated
- Sponsor
- Royal Bournemouth Hospital
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Royal Bournemouth Hospital. Primary endpoint: Glucose control. Started Jul 2005; status: terminated.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00135070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135070.